Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1994;89:578-587

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dilsizian, V.
Right arrow Articles by Bonow, R. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dilsizian, V.
Right arrow Articles by Bonow, R. O.

Circulation, Vol 89, 578-587, Copyright © 1994 by American Heart Association


ARTICLES

Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose [published erratum appears in Circulation 1995 Jun 15;91(12):3026]

V Dilsizian, JA Arrighi, JG Diodati, AA Quyyumi, K Alavi, SL Bacharach, JA Marin- Neto, PT Katsiyiannis and RO Bonow
Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892.

BACKGROUND: 99mTc-sestamibi and thallium imaging have similar accuracy when used for diagnostic purposes, but whether sestamibi provides accurate information regarding myocardial viability in patients with chronic coronary artery disease has not been established. Since there is minimal redistribution of sestamibi over time, it may overestimate nonviable myocardium in patients with left ventricular dysfunction, in whom blood flow may be reduced at rest. METHODS AND RESULTS: We studied 54 patients with chronic coronary artery disease with a mean ejection fraction of 34 +/- 14%. Patients underwent stress/redistribution/reinjection thallium tomography and, within a mean of 5 days, same-day rest/stress sestamibi imaging using the same exercise protocol and with patients achieving the same exercise duration. Of the 111 reversible thallium defects on either the redistribution or reinjection study, 40 (36%) were determined to be irreversible on the rest/stress sestamibi study, whereas only 3 of 63 irreversible thallium defects despite reinjection (5%) were classified to be reversible by sestamibi imaging. The concordance regarding reversibility of myocardial defects between thallium stress/redistribution/reinjection and same day rest/stress sestamibi studies was 75%. A subgroup of 25 patients also underwent positron emission tomography (PET) studies with 15O-labeled water and [18F]fluorodeoxyglucose (FDG) at rest after an oral glucose load. As in the overall group of 54 patients, there was concordance between thallium and sestamibi imaging regarding defect reversibility in 51 of 73 regions (70%). In the remaining 22 discordant regions (30%), 18 (82%) appeared irreversible by sestamibi imaging but were reversible by thallium imaging. Myocardial viability was confirmed in 17 of 18 regions, as evidenced by normal FDG uptake (10 regions) or FDG/blood flow mismatch (7 regions) on PET. These regions were present in 16 of the 25 patients studied (64%). We then explored methods to improve the sestamibi results. First, when the 18 discordant regions with irreversible sestamibi defects were further analyzed according to the severity of defects, 14 (78%) demonstrated only mild-to-moderate reduction in sestamibi activity (51% to 85% of normal activity), suggestive of predominantly viable myocardium, and the overall concordance between thallium and sestamibi studies increased to 93%. Second, when an additional 4-hour redistribution image was acquired in 18 patients after the injection of sestamibi at rest, 6 of 16 discordant irreversible regions (38%) on the rest/stress sestamibi study became reversible, thereby increasing the concordance between thallium and sestamibi studies to 82%. CONCLUSIONS: These data indicate that same-day rest/stress sestamibi imaging will incorrectly identify 36% of myocardial regions as being irreversibly impaired and nonviable compared with both thallium redistribution/reinjection and PET. However, the identification of reversible and viable myocardium can be greatly enhanced with sestamibi if an additional redistribution image is acquired after the rest sestamibi injection or if the severity of reduction in sestamibi activity within irreversible defects is considered.


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
F. M. Bengel, T. Higuchi, M. S. Javadi, and R. Lautamaki
Cardiac positron emission tomography.
J. Am. Coll. Cardiol., June 30, 2009; 54(1): 1 - 15.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
J. Garot, J. A. C. Lima, B. L. Gerber, S. Sampath, K. C. Wu, D. A. Bluemke, J. L. Prince, and N. F. Osman
Spatially Resolved Imaging of Myocardial Function with Strain-encoded MR: Comparison with Delayed Contrast-enhanced MR Imaging after Myocardial Infarction
Radiology, November 1, 2004; 233(2): 596 - 602.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S.R. Underwood, J. J Bax, J. v. Dahl, M. Y Henein, A. C van Rossum, E. R Schwarz, J.-L. Vanoverschelde, E. E.v. d. Wall, and W. Wijns
Imaging techniques for the assessment of myocardial hibernation: Report of a Study Group of the European Society of Cardiology
Eur. Heart J., May 2, 2004; 25(10): 815 - 836.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Z.-X. He, R.-F. Shi, Y.-J. Wu, Y.-Q. Tian, X.-J. Liu, S.-W. Wang, R. Shen, X.-W. Qin, R.-L. Gao, J. Narula, et al.
Direct Imaging of Exercise-Induced Myocardial Ischemia With Fluorine-18-Labeled Deoxyglucose and Tc-99m-Sestamibi in Coronary Artery Disease
Circulation, September 9, 2003; 108(10): 1208 - 1213.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
G. I.W. Galasko and A. Lahiri
The non-invasive assessment of hibernating myocardium in ischaemic cardiomyopathy--a myriad of techniques
Eur J Heart Fail, June 1, 2003; 5(3): 217 - 227.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. S. B. Beanlands, T. D. Ruddy, R. A. deKemp, R. M. Iwanochko, G. Coates, M. Freeman, C. Nahmias, P. Hendry, R. J. Burns, A. Lamy, et al.
Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function
J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1735 - 1743.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. Faraggi
The Continuing Story of 201Tl Reverse Redistribution: Reverse Redistribution Is Still Alive, but Is the Myocardium Still Viable?
J. Nucl. Med., May 1, 2002; 43(5): 628 - 631.
[Full Text] [PDF]


Home page
JNMHome page
B. B. Chin, G. Esposito, and D. L. Kraitchman
Myocardial Contractile Reserve and Perfusion Defect Severity with Rest and Stress Dobutamine 99mTc-Sestamibi SPECT in Canine Stunning and Subendocardial Infarction
J. Nucl. Med., April 1, 2002; 43(4): 540 - 550.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. S. Beanlands, T. D. Ruddy, M. Freeman, and G. Nichol
Patient management guided by viability imaging
J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1271 - 1272.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K.-C. Koch, J. vom Dahl, M. Wenderdel, B. Nowak, W. M. Schaefer, A. Sasse, C. Stellbrink, U. Buell, and P. Hanrath
Myocardial viability assessment by endocardial electroanatomic mapping: comparison with metabolic imaging and functional recovery after coronary revascularization
J. Am. Coll. Cardiol., July 1, 2001; 38(1): 91 - 98.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
K.F Fox, M.R Cowie, D.A Wood, A.J.S Coats, J.S.R Gibbs, S.R Underwood, R.M Turner, P.A Poole-Wilson, S.W Davies, and G.C Sutton
Coronary artery disease as the cause of incident heart failure in the population
Eur. Heart J., February 1, 2001; 22(3): 228 - 236.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
H.-M. J. Siebelink, P. K. Blanksma, H. J. G. M. Crijns, J. J. Bax, A. J. van Boven, T. Kingma, D. A. Piers, J. Pruim, P. L. Jager, W. Vaalburg, et al.
No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: A prospective, randomized comparison of patients with suspicion of jeopardized myocardium
J. Am. Coll. Cardiol., January 1, 2001; 37(1): 81 - 88.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. G. Danias
Stress testing and electron beam computed tomography for evaluation of patients with suspected coronary artery disease
J. Am. Coll. Cardiol., January 1, 2001; 37(1): 334 - 335.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Rickers, K. Sasse, R. Buchert, H. Stern, J.o. van den Hoff, M. Lubeck, and J. Weil
Myocardial viability assessed by positron emission tomography in infants and children after the arterial switch operation and suspected infarction
J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1676 - 1683.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. M. Shavelle, M. J. Budoff, D. H. LaMont, R. M. Shavelle, J. M. Kennedy, and B. H. Brundage
Exercise testing and electron beam computed tomography in the evaluation of coronary artery disease
J. Am. Coll. Cardiol., July 1, 2000; 36(1): 32 - 38.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H. Sato, T. Iwasaki, T. Toyama, Y. Kaneko, T. Inoue, K. Endo, and R. Nagai
Prediction of Functional Recovery After Revascularization in Coronary Artery Disease Using 18F-FDG and 123I-BMIPP SPECT*
Chest, January 1, 2000; 117(1): 65 - 72.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. Barilla, G. De Vincentis, E. Mangieri, M. Ciavolella, G. Pannitteri, F. Scopinaro, G. Critelli, and P. P. Campa
Recovery of contractility of viable myocardium during inotropic stimulation is not dependent on an increase of myocardial blood flow in the absence of collateral filling
J. Am. Coll. Cardiol., March 1, 1999; 33(3): 697 - 704.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
K.F. Fox, M.R. Cowie, D.A. Wood, A.J.S. Coats, P.A. Poole-Wilson, and G.C. Sutton
New perspectives on heart failure due to myocardial ischaemia
Eur. Heart J., February 2, 1999; 20(4): 256 - 262.
[PDF]


Home page
ANGIOLOGYHome page
B. Lagana, O. Schillaci, L. Tubani, R. Gentile, R. Danieli, R. Coviello, L. Baratta, F. Scopinaro, and B. Lagana
Lupus Carditis: Evaluation with Technetium-99m MIBI Myocardial SPECT and Heart Rate Variability
Angiology, February 1, 1999; 50(2): 143 - 148.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
I. Matsunari, G. Boning, S. I. Ziegler, S. G. Nekolla, J. C. Stollfuss, I. Kosa, E. P. Ficaro, and M. Schwaiger
Attenuation-corrected 99mTc-tetrofosmin single-photon emission computed tomography in the detection of viable myocardium: comparison with positron emission tomography using 18F-fluorodeoxyglucose
J. Am. Coll. Cardiol., October 1, 1998; 32(4): 927 - 935.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. A. Schneider, E. Voth, S. Gawlich, F. M. Baer, M. Horst, H. Schicha, E. Erdmann, and U. Sechtem
Significance of rest technetium-99m sestamibi imaging for the prediction of improvement of left ventricular dysfunction after q wave myocardial infarction: importance of infarct location adjusted thresholds
J. Am. Coll. Cardiol., September 1, 1998; 32(3): 648 - 654.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Cinca, A. Garcia-Burillo, A. Carreno, J. Castell, M. Warren, J. Candell-Riera, A. Domingo, and J Soler-Soler
Differential uptake of myocardial perfusion radiotracers in normal, infarcted, and acutely ischemic peri-infarction myocardium
Cardiovasc Res, April 1, 1998; 38(1): 91 - 97.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. A. Dakik, J. F. Howell, G. M. Lawrie, R. Espada, D. G. Weilbaecher, Z.-X. He, J. J. Mahmarian, and M. S. Verani
Assessment of Myocardial Viability With 99mTc-Sestamibi Tomography Before Coronary Bypass Graft Surgery : Correlation With Histopathology and Postoperative Improvement in Cardiac Function
Circulation, November 4, 1997; 96(9): 2892 - 2898.
[Abstract] [Full Text]


Home page
CirculationHome page
A. Elsasser, M. Schlepper, W.-P. Klovekorn, W.-j. Cai, R. Zimmermann, K.-D. Muller, R. Strasser, S. Kostin, C. Gagel, B. Munkel, et al.
Hibernating Myocardium : An Incomplete Adaptation to Ischemia
Circulation, November 4, 1997; 96(9): 2920 - 2931.
[Abstract] [Full Text]


Home page
CirculationHome page
G. Vanzetto, D. A. Calnon, M. Ruiz, D. D. Watson, R. Pasqualini, G. A. Beller, and D. K. Glover
Myocardial Uptake and Redistribution of 99mTc-N-NOET in Dogs With Either Sustained Coronary Low Flow or Transient Coronary Occlusion : Comparison With 201Tl and Myocardial Blood Flow
Circulation, October 7, 1997; 96(7): 2325 - 2331.
[Abstract] [Full Text]


Home page
CirculationHome page
Z.-X. He, R. Medrano, J. T. Hays, J. J. Mahmarian, and M. S. Verani
Nitroglycerin-Augmented 201Tl Reinjection Enhances Detection of Reversible Myocardial Hypoperfusion : A Randomized, Double-Blind, Parallel, Placebo-Controlled Trial
Circulation, April 1, 1997; 95(7): 1799 - 1805.
[Abstract] [Full Text]


Home page
CirculationHome page
H. G. Wolpers, W. Burchert, J. van den Hoff, R. Weinhardt, G.-J. Meyer, and P. R. Lichtlen
Assessment of Myocardial Viability by Use of 11C-Acetate and Positron Emission Tomography : Threshold Criteria of Reversible Dysfunction
Circulation, March 18, 1997; 95(6): 1417 - 1424.
[Abstract] [Full Text]


Home page
CirculationHome page
G. Ambrosio, S. Betocchi, L. Pace, M. A. Losi, P. Perrone-Filardi, A. Soricelli, F. Piscione, J. Taube, F. Squame, M. Salvatore, et al.
Prolonged Impairment of Regional Contractile Function After Resolution of Exercise-Induced Angina: Evidence of Myocardial Stunning in Patients With Coronary Artery Disease
Circulation, November 15, 1996; 94(10): 2455 - 2464.
[Abstract] [Full Text]


Home page
CirculationHome page
N. Takahashi, C. P. Reinhardt, R. Marcel, and J. A. Leppo
Myocardial Uptake of 99mTc-Tetrofosmin, Sestamibi, and 201Tl in a Model of Acute Coronary Reperfusion
Circulation, November 15, 1996; 94(10): 2605 - 2613.
[Abstract] [Full Text]


Home page
CirculationHome page
R. Medrano, R. W. Lowry, J. B. Young, D. G. Weilbaecher, L. H. Michael, I. Afridi, Z.-X. He, J. J. Mahmarian, and M. S. Verani
Assessment of Myocardial Viability With 99mTc Sestamibi in Patients Undergoing Cardiac Transplantation: A Scintigraphic/Pathological Study
Circulation, September 1, 1996; 94(5): 1010 - 1017.
[Abstract] [Full Text]


Home page
CirculationHome page
V. Sansoy, D. K. Glover, D. D. Watson, M. Ruiz, W. H. Smith, J. P. Simanis, and G. A. Beller
Comparison of Thallium-201 Resting Redistribution With Technetium-99m–Sestamibi Uptake and Functional Response to Dobutamine for Assessment of Myocardial Viability
Circulation, August 15, 1995; 92(4): 994 - 1004.
[Abstract] [Full Text]


Home page
CirculationHome page
T. D. Miller, T. F. Christian, M. R. Hopfenspirger, D. O. Hodge, B. J. Gersh, and R. J. Gibbons
Infarct Size After Acute Myocardial Infarction Measured by Quantitative Tomographic 99mTc Sestamibi Imaging Predicts Subsequent Mortality
Circulation, August 1, 1995; 92(3): 334 - 341.
[Abstract] [Full Text]